BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34809697)

  • 1. Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways.
    Labrèche C; Cook DP; Abou-Hamad J; Pascoal J; Pryce BR; Al-Zahrani KN; Sabourin LA
    Breast Cancer Res; 2021 Nov; 23(1):107. PubMed ID: 34809697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
    Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models.
    Issa A; Gill JW; Heideman MR; Sahin O; Wiemann S; Dey JH; Hynes NE
    Breast Cancer Res; 2013 Jan; 15(1):R8. PubMed ID: 23343422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
    Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
    PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
    Ma K; Zhang C; Li W
    Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
    Sharpe R; Pearson A; Herrera-Abreu MT; Johnson D; Mackay A; Welti JC; Natrajan R; Reynolds AR; Reis-Filho JS; Ashworth A; Turner NC
    Clin Cancer Res; 2011 Aug; 17(16):5275-86. PubMed ID: 21712446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.
    Hosonaga M; Arima Y; Sugihara E; Kohno N; Saya H
    Cancer Sci; 2014 Jul; 105(7):779-87. PubMed ID: 24754246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
    Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
    Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
    Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
    Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.
    Wang SE; Xiang B; Guix M; Olivares MG; Parker J; Chung CH; Pandiella A; Arteaga CL
    Mol Cell Biol; 2008 Sep; 28(18):5605-20. PubMed ID: 18625725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin3 is required for FGF-2-induced migration of human breast cancers.
    Cao XC; Zhang WR; Cao WF; Liu BW; Zhang F; Zhao HM; Meng R; Zhang L; Niu RF; Hao XS; Zhang B
    PLoS One; 2013; 8(2):e56735. PubMed ID: 23468877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of periostin in breast cancer cells.
    Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Matkowski R; Wojnar A; Rys J; Ugorski M; Dziegiel P
    Int J Oncol; 2017 Oct; 51(4):1300-1310. PubMed ID: 28902360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.
    Park SY; Piao Y; Jeong KJ; Dong J; de Groot JF
    Mol Cancer Ther; 2016 Sep; 15(9):2187-97. PubMed ID: 27307601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
    Nencioni A; Cea M; Garuti A; Passalacqua M; Raffaghello L; Soncini D; Moran E; Zoppoli G; Pistoia V; Patrone F; Ballestrero A
    PLoS One; 2010 Feb; 5(2):e9024. PubMed ID: 20126311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
    Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.